| abstract |
The invention relates to a composition comprising at least one XAP peptide, in which X represents an empty set or a valine, for use in the prevention and / or treatment of pathologies related to alpha-glucosidase. The invention also relates to the use of a hydrolyzate of at least one protein, containing said protein, or being constituted by at least 0.05% to <5% or at least 5% of XAP motifs, in which X represents an empty set or a valine, for use in the prevention and / or treatment of pathologies related to alpha-glucosidase. |